Inge Snoeren

551 total citations
9 papers, 209 citations indexed

About

Inge Snoeren is a scholar working on Genetics, Hematology and Molecular Biology. According to data from OpenAlex, Inge Snoeren has authored 9 papers receiving a total of 209 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Genetics, 5 papers in Hematology and 2 papers in Molecular Biology. Recurrent topics in Inge Snoeren's work include Acute Myeloid Leukemia Research (2 papers), Mesenchymal stem cell research (2 papers) and Alzheimer's disease research and treatments (2 papers). Inge Snoeren is often cited by papers focused on Acute Myeloid Leukemia Research (2 papers), Mesenchymal stem cell research (2 papers) and Alzheimer's disease research and treatments (2 papers). Inge Snoeren collaborates with scholars based in Germany, Netherlands and United Kingdom. Inge Snoeren's co-authors include Oyinkan Sofola-Adesakin, Linda Partridge, Mobina Khericha, Dobril Ivanov, Janet M. Thornton, Fiona Kerr, Jorge Iván Castillo-Quan, Pedro Martı́nez, Hélène Bertrand and Helena M. Cochemé and has published in prestigious journals such as PLoS Genetics, Leukemia and Experimental Hematology.

In The Last Decade

Inge Snoeren

7 papers receiving 209 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Inge Snoeren Germany 5 110 59 26 25 21 9 209
Preetpal S. Sidhu United States 11 103 0.9× 29 0.5× 63 2.4× 19 0.8× 22 1.0× 18 315
Min Joung Lee South Korea 13 172 1.6× 37 0.6× 9 0.3× 16 0.6× 19 0.9× 23 344
Xiongzhi Quan China 8 183 1.7× 74 1.3× 12 0.5× 33 1.3× 26 1.2× 12 341
Sally E. Thomas United Kingdom 7 148 1.3× 122 2.1× 33 1.3× 28 1.1× 13 0.6× 7 370
Fengju Jia China 10 100 0.9× 71 1.2× 16 0.6× 47 1.9× 38 1.8× 17 297
Yanli Xing China 9 185 1.7× 21 0.4× 36 1.4× 20 0.8× 21 1.0× 18 322
A. Costa Italy 9 117 1.1× 34 0.6× 34 1.3× 18 0.7× 52 2.5× 22 336
Diane Baus United States 6 348 3.2× 112 1.9× 10 0.4× 25 1.0× 16 0.8× 6 485
Tracy Ann Perry United States 5 62 0.6× 41 0.7× 23 0.9× 17 0.7× 25 1.2× 6 182
Vijayalakshmi Mahadevan India 11 297 2.7× 28 0.5× 13 0.5× 23 0.9× 22 1.0× 13 425

Countries citing papers authored by Inge Snoeren

Since Specialization
Citations

This map shows the geographic impact of Inge Snoeren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Inge Snoeren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Inge Snoeren more than expected).

Fields of papers citing papers by Inge Snoeren

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Inge Snoeren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Inge Snoeren. The network helps show where Inge Snoeren may publish in the future.

Co-authorship network of co-authors of Inge Snoeren

This figure shows the co-authorship network connecting the top 25 collaborators of Inge Snoeren. A scholar is included among the top collaborators of Inge Snoeren based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Inge Snoeren. Inge Snoeren is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Gleitz, Hélène F.E., Inge Snoeren, Charlotte Boys, et al.. (2025). Inhibiting the alarmin‐driven hematopoiesis‐stromal cell crosstalk in primary myelofibrosis ameliorates bone marrow fibrosis. HemaSphere. 9(8). e70179–e70179.
2.
Snoeren, Inge, Eric M. Bindels, Stephani Schmitz, et al.. (2023). Collaborative effect of Csnk1a1 haploinsufficiency and mutant p53 in Myc induction can promote leukemic transformation. Blood Advances. 8(3). 766–779.
3.
Gleitz, Hélène F.E., Inge Snoeren, James S. Nagai, et al.. (2023). S205: INHIBITING THE ALARMIN-DRIVEN HEMATOPOIESIS-STROMAL CELLS CROSSTALK IN PRIMARY MYELOFIBROSIS AMELIORATES BONE MARROW FIBROSIS. HemaSphere. 7(S3). e36177f7–e36177f7. 2 indexed citations
4.
Snoeren, Inge, James S. Nagai, Nils B. Leimkühler, et al.. (2022). Single-cell analysis of cultured bone marrow stromal cells reveals high similarity to fibroblasts in situ. Experimental Hematology. 110. 28–33. 6 indexed citations
5.
Gleitz, Hélène F.E., et al.. (2021). Isolation of human bone marrow stromal cells from bone marrow biopsies for single-cell RNA sequencing. STAR Protocols. 2(2). 100538–100538. 4 indexed citations
6.
Niccoli, Teresa, Fiona Kerr, Inge Snoeren, et al.. (2021). Activating transcription factor 4-dependent lactate dehydrogenase activation as a protective response to amyloid beta toxicity. Brain Communications. 3(2). fcab053–fcab053. 9 indexed citations
7.
Snoeren, Inge, Susanne Ziegler, Mónica Ventura Ferreira, et al.. (2019). Rps14, Csnk1a1 and miRNA145/miRNA146a deficiency cooperate in the clinical phenotype and activation of the innate immune system in the 5q- syndrome. Leukemia. 33(7). 1759–1772. 36 indexed citations
8.
Kerr, Fiona, Oyinkan Sofola-Adesakin, Dobril Ivanov, et al.. (2017). Direct Keap1-Nrf2 disruption as a potential therapeutic target for Alzheimer’s disease. PLoS Genetics. 13(3). e1006593–e1006593. 121 indexed citations
9.
Sofola-Adesakin, Oyinkan, Mobina Khericha, Inge Snoeren, Leo Tsuda, & Linda Partridge. (2016). pGluAβ increases accumulation of Aβ in vivo and exacerbates its toxicity. Acta Neuropathologica Communications. 4(1). 109–109. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026